STOCK TITAN
  1. Home
  2. Sec-filings
  3. PRE
  4. [6-K] Prenetics Global Ltd Current Report (Foreign Issuer)

Prenetics (NASDAQ: PRE) exits Bitcoin, eyes larger buybacks and IM8 growth

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Prenetics Global Limited plans to fully divest its treasury holdings of approximately 510 Bitcoin, targeting completion by May 14, 2026. Based on recent prices of about $80,000 per BTC, the company currently expects gross proceeds of roughly $40 million.

After the sale, Prenetics expects total cash, current financial assets and escrowed consideration to increase from about $112 million as of March 31, 2026 to approximately $145 million to $150 million, with no indebtedness. The Board has adopted a policy not to purchase Bitcoin or other digital assets going forward, focusing capital on the IM8 consumer health business, which is targeting $180 million to $200 million in FY2026 revenue.

The company intends to use divestment proceeds to potentially expand its up to $40 million share repurchase program, accelerate IM8 marketing, fund new product launches in Q4 2026 and support international expansion across more than 40 countries. Prenetics expects to report selected Q1 FY2026 results on May 14, 2026, when it also plans to disclose final Bitcoin sale proceeds and volume-weighted average price.

Positive

  • Balance sheet de-risking and liquidity boost: Exiting approximately 510 BTC for expected gross proceeds around $40 million is projected to raise total cash, current financial assets and escrow from about $112 million to roughly $145–$150 million with no debt.
  • Capital focused on core IM8 growth and buybacks: The Board ended future digital asset purchases and plans to direct proceeds toward the IM8 business, including potential expansion of the up to $40 million share repurchase program, marketing, product launches and global expansion.

Negative

  • None.

Insights

Prenetics exits Bitcoin to bolster cash and fund core IM8 growth and buybacks.

Prenetics Global Limited is liquidating about 510 Bitcoin, with indicative gross proceeds of roughly $40 million at recent prices. This would lift total cash, current financial assets and escrow from about $112 million as of March 31, 2026 to an estimated $145–$150 million, while maintaining no debt.

The Board has also formally ended Bitcoin and digital asset purchases, pivoting treasury strategy toward the IM8 consumer health business, which is targeting $180–$200 million in FY2026 revenue. Management cites IM8 as its highest‑conviction growth asset, suggesting capital deployment will prioritize marketing, product expansion and international reach.

Planned uses of proceeds include a potential expansion of the existing up to $40 million share repurchase program, increased direct‑to‑consumer marketing, new SKUs in Q4 2026 and broader international penetration across 40+ countries. Final Bitcoin sale proceeds and volume‑weighted average price are expected to be disclosed with selected Q1 FY2026 results on May 14, 2026.

Bitcoin holdings to be sold approximately 510 BTC Treasury divestment authorized May 1, 2026
Indicative gross proceeds approximately $40 million Based on recent Bitcoin price of about $80,000 per BTC
Bitcoin reference price approximately $80,000 per BTC Used to illustrate potential divestment proceeds
Cash and equivalents approximately $56 million As of March 31, 2026
Current financial assets at fair value approximately $50 million As of March 31, 2026
Cash consideration held under escrow approximately $6 million As of March 31, 2026
Total liquid resources pre-divestment approximately $112 million Aggregate of cash, financial assets and escrow as of March 31, 2026
Expected total liquid resources post-divestment approximately $145–$150 million After Bitcoin divestment, subject to final price and fees
IM8 FY2026 revenue target $180–$200 million Full-year FY2026 guidance for flagship IM8 brand
Share repurchase program size up to $40 million Authorized March 6, 2026; may be expanded using divestment proceeds
Bitcoin treasury holdings financial
"authorized the complete divestment of the Company’s entire Bitcoin treasury holdings of approximately 510 Bitcoin"
share repurchase program financial
"the Board authorized a share repurchase program of up to $40 million"
A share repurchase program is when a company buys back its own shares from the marketplace. This reduces the total number of shares available, which can increase the value of each remaining share and signal confidence in the company's prospects. For investors, it often suggests that the company believes its stock is undervalued or that it has extra cash to return to shareholders.
current financial assets at fair value through profit or loss financial
"current financial assets at fair value through profit or loss of approximately $50 million"
cash consideration held under escrow financial
"approximately $6 million of cash consideration held under escrow"
volume-weighted average sale price financial
"The Company will disclose the final aggregate proceeds and volume-weighted average sale price."
forward-looking statements regulatory
"This report on Form 6-K contains forward-looking statements."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

What did Prenetics Global Limited (PRE) announce in this Form 6-K?
Prenetics Global Limited announced that its board authorized the complete sale of its approximately 510 Bitcoin treasury holdings by May 14, 2026. The company is exiting digital assets and redirecting capital toward its IM8 consumer health business, share repurchases, marketing, product development and international growth.

How much cash does Prenetics (PRE) expect from selling its Bitcoin holdings?
Prenetics currently expects gross proceeds of about $40 million from selling roughly 510 Bitcoin, based on recent prices near $80,000 per BTC. Actual proceeds will depend on market prices, execution conditions and fees during the sale period and may be materially higher or lower.

How will the Bitcoin sale affect Prenetics’ (PRE) cash position?
As of March 31, 2026, Prenetics reported about $56 million in cash, $50 million in current financial assets and $6 million in escrow, totaling roughly $112 million. After the Bitcoin divestment, it expects this total to rise to approximately $145–$150 million, with no outstanding indebtedness.

What is Prenetics’ (PRE) new policy on Bitcoin and digital assets?
The board adopted a policy that Prenetics will not purchase Bitcoin or any other digital assets in the future. Instead, its treasury and capital allocation strategy will focus exclusively on supporting IM8 consumer health operations, including growth initiatives across marketing, product expansion and international markets.

How does Prenetics (PRE) plan to use the Bitcoin sale proceeds?
Prenetics plans to use net proceeds to potentially expand its up to $40 million share repurchase program, increase IM8 direct-to-consumer marketing, fund new product SKUs launching in Q4 2026, and support deeper international penetration for IM8 across more than 40 countries.

What revenue is Prenetics (PRE) targeting for its IM8 business in FY2026?
The company’s IM8 flagship brand is targeting full-year FY2026 revenue of $180 million to $200 million. Management and the board view IM8 as Prenetics’ highest-conviction growth asset, so they intend to deploy treasury capital primarily to support this business and its expansion initiatives.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 6-K: How Foreign Companies Report to the SEC →

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
Form 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of May 2026
 
Commission File Number 001-41401
 
 
Prenetics Global Limited
 
 
Unit 703-706, K11 Atelier
728 King’s Road, Quarry Bay
Hong Kong

(Addresses of principal executive offices)
 

 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐
 

 
 





EXPLANATORY NOTE

On May 1, 2026, the Board of Directors (the “Board”) of Prenetics Global Limited (NASDAQ: PRE) (the “Company”) authorized the complete divestment of the Company’s entire Bitcoin treasury holdings of approximately 510 Bitcoin (“BTC”). The Company expects to execute the sale through institutional channels, including over-the-counter desks, with all sales targeted to be completed on or before May 14, 2026. Aggregate gross proceeds will depend on prevailing Bitcoin prices and execution conditions and fees during the sale period; based on recent market prices of approximately $80,000 per BTC, the Company currently expects gross proceeds of approximately $40 million, although actual proceeds may be materially higher or lower.

The Board has adopted a policy that the Company will not purchase Bitcoin or any other digital assets in the future. The Company’s treasury and capital allocation strategy will be focused exclusively on supporting its core IM8 consumer health business operations and growth initiatives.

Strategic Rationale

With the Company’s flagship brand, IM8, now operating at significant scale and targeting to deliver $180 million to $200 million in full-year FY2026 revenue, the Board and management believe that the Company’s capital is most productively deployed in support of its highest-conviction growth asset.

Intended Use of Proceeds

The Company intends to use the net proceeds from the Bitcoin divestment for the following purposes:
•Potential expansion of the Company’s share repurchase program. On March 6, 2026, the Board authorized a share repurchase program of up to $40 million. The Company may use a portion of the divestment proceeds to increase the size of this program, reflecting the Board’s confidence in the intrinsic value of the Company’s equity;
•Acceleration of IM8 direct-to-consumer marketing investment, capitalizing on demonstrated channel unit economics across digital advertising platforms;
•Product pipeline expansion, including new SKU launches in Q4 of 2026; and
•International market penetration, supporting IM8’s continued expansion across 40+ countries.

Cash Position Following Divestment

As of March 31, 2026, the Company had cash and cash equivalents of approximately $56 million, current financial assets at fair value through profit or loss of approximately $50 million, and approximately $6 million of cash consideration held under escrow1, for a total of approximately $112 million. Following completion of the Bitcoin divestment, and assuming proceeds to us of approximately $40 million (subject to final disposal price and execution fees) and ordinary course operating activity, the Company expects to have cash and cash equivalents, current financial assets at fair value through profit or loss, and cash consideration held under escrow, for a total of approximately $145 million to $150 million2 with no outstanding indebtedness.

Upcoming Earnings Report and Completion Disclosure

The Company expects to report its first quarter FY2026 selected financial results on May 14, 2026, by which date the Company expects to have completed all of the Bitcoin sales. The Company will disclose the final aggregate proceeds and volume-weighted average sale price. Any realized gain or loss will be reflected in the Company’s unaudited consolidated financial statements for the quarter ending June 30, 2026.

Forward-Looking Statements

1 Representing portions of gross proceeds of the ACT Genomics sale and Insighta sale transactions held in escrow pending fulfillment of customary release conditions.
2 The financial figures in this paragraph are preliminary and unaudited and remain subject to completion of the Company’s quarterly financial closing process.


This report on Form 6-K contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s goals, targets, projections, outlooks, beliefs, expectations, strategy, plans, objectives of management for future operations of the Company, and growth opportunities are forward-looking statements. Our guidance reflects management’s current estimates and assumptions as of the date of this release, is subject to significant risks and uncertainties, and is not a guarantee of future performance. Actual results may differ materially. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” “guidance,” “outlook,” “forecast,” or other similar expressions. Forward-looking statements are based upon estimates and forecasts and reflect the views, assumptions, expectations, and opinions of the Company, which involve inherent risks and uncertainties, and therefore they should not be relied upon as being necessarily indicative of future results. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to: fluctuations in the price of Bitcoin during the divestment period; changes in market conditions; the Company may not be able to maintain and enhance its IM8 business and brand if it suffers negative publicity or fails to maintain a strong base of engaged customers and content creators, or otherwise fails to meet customers’ expectations; the Company’s ability to further develop and grow its business, including new products and services; and its ability to identify and execute on M&A opportunities. In addition to the foregoing factors, you should also carefully consider the other risks and uncertainties described in the “Risk Factors” section of the Company’s most recent registration statement and the prospectus therein, and the other documents filed by the Company from time to time with the U.S. Securities and Exchange Commission. Unless otherwise specified, all information provided in this report is as of the date of this report, and the Company does not undertake any duty to update such information, except as required under applicable law. Nothing in this report on Form 6-K constitutes an offer to sell, or the solicitation of an offer to buy, any securities of the Company.


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 Prenetics Global Limited
  
 By:/s/ Danny Sheng Wu Yeung
 Name:Danny Sheng Wu Yeung
 Title:Chief Executive Officer
  
Date: May 4, 2026 
 
 


Source: View Original Filing on SEC EDGAR